International Biotechnology Trust (CHIX:IBTL) Return-on-Tangible-Equity : 5.05% (As of Feb. 2025)

International Biotechnology Trust Return-on-Tangible-Equity Chart

International Biotechnology Trust Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24
Return-on-Tangible-Equity		Get a 7-Day Free Trial					20.41	9.18	-7.38	2.45	14.07

International Biotechnology Trust Semi-Annual Data
	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24	Feb25
Return-on-Tangible-Equity	Get a 7-Day Free Trial															11.69	-7.17	20.35	7.41	5.05

Competitive Comparison of International Biotechnology Trust's Return-on-Tangible-Equity

For the Biotechnology subindustry, International Biotechnology Trust's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Return-on-Tangible-Equity falls into.

International Biotechnology Trust Return-on-Tangible-Equity Calculation

International Biotechnology Trust's annualized Return-on-Tangible-Equity for the fiscal year that ended in Aug. 2024 is calculated as

International Biotechnology Trust's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Feb. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

International Biotechnology Trust  (CHIX:IBTl) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.

Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.

International Biotechnology Trust Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust Business Description